Form 8-K - Current report:
SEC Accession No. 0001493152-25-004501
Filing Date
2025-01-31
Accepted
2025-01-31 17:25:30
Documents
22
Period of Report
2025-01-27
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 64191
2 ex10-1.htm EX-10.1 31538
3 ex10-2.htm EX-10.2 47997
4 ex10-3.htm EX-10.3 48635
5 ex10-4.htm EX-10.4 60790
6 ex10-5.htm EX-10.5 57623
7 ex10-6.htm EX-10.6 43618
8 ex10-7.htm EX-10.7 118111
9 ex10-1_001.jpg GRAPHIC 13319
10 ex10-1_002.jpg GRAPHIC 136781
  Complete submission text file 0001493152-25-004501.txt   935677

Data Files

Seq Description Document Type Size
11 XBRL SCHEMA FILE mgrx-20250127.xsd EX-101.SCH 3033
12 XBRL LABEL FILE mgrx-20250127_lab.xml EX-101.LAB 34240
13 XBRL PRESENTATION FILE mgrx-20250127_pre.xml EX-101.PRE 22371
24 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3808
Mailing Address 15110 DALLAS PKWY, SUITE 600 DALLAS TX 75248
Business Address 15110 DALLAS PKWY, SUITE 600 DALLAS TX 75248 (833) 626-4679
MANGOCEUTICALS, INC. (Filer) CIK: 0001938046 (see all company filings)

EIN.: 873841292 | State of Incorp.: TX | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41615 | Film No.: 25579551
SIC: 8090 Services-Misc Health & Allied Services, NEC
(CF Office: 03 Life Sciences)